Grifols SA
MAD:GRF
Grifols SA
Cost of Revenue
Grifols SA
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Grifols SA
MAD:GRF
|
Cost of Revenue
-€4.1B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
Oryzon Genomics SA
MAD:ORY
|
Cost of Revenue
-€1.1m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
N/A
|
|
Pharma Mar SA
MAD:PHM
|
Cost of Revenue
-€9.2m
|
CAGR 3-Years
19%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
12%
|
|
Biotechnology Assets SA
MAD:BST
|
Cost of Revenue
-€1.1m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
See Also
What is Grifols SA's Cost of Revenue?
Cost of Revenue
-4.1B
EUR
Based on the financial report for Dec 31, 2023, Grifols SA's Cost of Revenue amounts to -4.1B EUR.
What is Grifols SA's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-11%
Over the last year, the Cost of Revenue growth was -7%. The average annual Cost of Revenue growth rates for Grifols SA have been -10% over the past three years , -11% over the past five years .